Sponsor or institution

Clinical trials and research at British Columbia Cancer Agency

• 24Clinical trials
• 2Countries

Newest trials

All recruiting trials (24)

• First-line Sacituzumab Govitecan for Advanced Untreated Triple-Negative Breast Cancer

  This study tests whether Sacituzumab Govitecan can slow disease progression when given as a first treatment to adults with advanced triple-negative breast cancer who have not yet received treatment in the advanced setting.

  Recruiting Phase 2 British Columbia Cancer Agency · Vancouver, British Columbia · NCT07299409

• Using Hand Grip Tests to Understand Muscle Strength in Pancreatic Cancer

  This study tests whether hand grip strength can be measured during regular clinic visits and whether grip strength relates to body composition, wellbeing, and tumor response in adults with pancreatic ductal adenocarcinoma.

  Recruiting British Columbia Cancer Agency · Vancouver, British Columbia · NCT07255001

• Stereotactic ablative radiotherapy versus single‑fraction palliative radiotherapy for oligoprogressive metastatic cancer

  This trial will test whether stereotactic ablative radiotherapy (SABR) works better than single‑fraction palliative radiotherapy (8 Gy) for people with 1–5 oligoprogressive metastatic lesions to delay the need for next‑line systemic therapy and improve quality of life.

  Recruiting British Columbia Cancer Agency · Surrey, British Columbia · NCT06918951

• Single vs. short-course radiation for partial breast cancer

  This trial tests whether a single-fraction partial breast irradiation is as effective and tolerable as the standard multi-fraction approach for women 40 and older with early-stage breast cancer.

  Recruiting British Columbia Cancer Agency · Prince George, British Columbia · NCT06885671

• Two- versus five-fraction stereotactic ablative radiotherapy for intermediate-risk prostate cancer

  This trial tests whether giving prostate SABR in 2 treatments instead of 5 is as safe and effective for men with intermediate-risk prostate cancer.

  Recruiting at 2 sites Phase 2 British Columbia Cancer Agency · Surrey, British Columbia and 1 other locations · NCT06835725

• Adaptive vs non-adaptive radiotherapy and bladder filling directions for localized prostate cancer

  This trial tests whether daily adaptive radiotherapy plus customized bladder filling instructions improve outcomes for men with intermediate- or high-risk localized prostate cancer.

  Recruiting Phase 2 British Columbia Cancer Agency · Vancouver, British Columbia · NCT06678126

• Genomic and transcriptomic markers predicting response to sacituzumab govitecan after trastuzumab deruxtecan in ER+/HER2-low metastatic breast cancer

  This trial will test whether DNA and RNA features from a fresh tumor biopsy can predict who responds to sacituzumab govitecan in people with ER-positive, HER2-low metastatic breast cancer who progressed after trastuzumab deruxtecan.

  Recruiting Phase 2 British Columbia Cancer Agency · Vancouver, British Columbia · NCT06665178

• Improving early lung cancer detection in diverse populations

  This study is trying to find a new way to spot lung cancer early in people who aren't eligible for regular screenings by using breath samples and blood tests to tell the difference between cancerous and non-cancerous growths.

  Recruiting British Columbia Cancer Agency · Vancouver, British Columbia · NCT06628102

• Tumor DNA and protein testing to understand pancreatic cancer treatment response

  This trial will test whether measuring tumor DNA and proteins from people with resectable or locally advanced pancreatic ductal adenocarcinoma can be done quickly enough and provide information about how their cancer responds to standard chemotherapy.

  Recruiting British Columbia Cancer Agency · Vancouver, British Columbia · NCT06574620

• Assessing real-world quality of life and survival in cancer treatment

  This study is trying to see how well certain cancer treatments that haven't been fully proven yet can improve the quality of life and survival for patients.

  Recruiting British Columbia Cancer Agency · Vancouver, British Columbia · NCT06242912

• Seeing CXCR4 in lymphoma and leukemia with a new PET tracer

  This study tests a new PET tracer called 18F-BL40 to see if it can image CXCR4-expressing cancers and compares it with the standard 18F-FDG in adults with various blood cancers.

  Recruiting British Columbia Cancer Agency · Vancouver, British Columbia · NCT06224309

• CLIC-2201 treatment for relapsed B cell cancers

  This study is testing a new CAR-T cell therapy called CLIC-2201 to see if it can help people with relapsed B cell cancers feel better and improve their treatment outcomes.

  Recruiting at 7 sites Phase 1 British Columbia Cancer Agency · Calgary, Alberta and 6 other locations · NCT06208735

• Investigating HDR Brachytherapy for Prostate Cancer

  This study is testing how effective High Dose Rate brachytherapy is for treating localized prostate cancer and looking at how it affects tumor changes and the immune system.

  Recruiting British Columbia Cancer Agency · Kelowna, British Columbia · NCT06200974

• Comparing single and multiple doses of radiation therapy for treating oligometastatic disease

  This study is testing whether one dose or several doses of radiation therapy works better and is safer for people with oligometastatic disease, while also looking at how it affects their quality of life and costs.

  Recruiting at 13 sites British Columbia Cancer Agency · Kelowna, British Columbia and 13 other locations · NCT05784428

• Stratifying vulvar squamous cell carcinoma by HPV and p53 to guide surgical excision

  See if using HPV (p16) and p53 test results to guide how much tissue is removed during surgery helps women with early-stage vulvar squamous cell carcinoma.

  Recruiting British Columbia Cancer Agency · Vancouver, British Columbia · NCT05576831

• Analyzing spinal fluid in lung cancer patients with leptomeningeal disease

  This study is trying to see how the spinal fluid and blood of lung cancer patients with a specific mutation differ, to better understand their condition and how it affects their quality of life.

  Recruiting British Columbia Cancer Agency · Vancouver, British Columbia · NCT05257967

• Managing glucose levels in pancreatic cancer patients

  This study is testing if closely managing blood sugar levels can help people with pancreatic cancer who are receiving standard chemotherapy feel better and improve their treatment outcomes.

  Recruiting at 2 sites British Columbia Cancer Agency · Vancouver, British Columbia and 1 other locations · NCT05132244

• Assessing quality of life and survival in patients with rare cancers receiving targeted therapy

  This study is trying to see if targeted therapies can improve the quality of life and survival for people with advanced rare cancers.

  Recruiting British Columbia Cancer Agency · Vancouver, British Columbia · NCT04814095

• Comparing different radiation therapies for treating oligometastatic prostate cancer

  This study is testing whether new types of radiation therapy can help men with oligometastatic prostate cancer feel better and live longer compared to standard treatment.

  Recruiting at 3 sites British Columbia Cancer Agency · Kelowna, British Columbia and 3 other locations · NCT04610372

• Effects of Atezolizumab on Cancer Patients with Sensitive Tumor DNA or RNA

  This study is testing if atezolizumab can help cancer patients with certain tumor types that show they might respond well to the treatment.

  Recruiting Phase 2 British Columbia Cancer Agency · Vancouver, British Columbia and 1 other locations · NCT04273061

• Improving treatment for advanced prostate cancer using advanced imaging techniques

  This study is testing a new way to treat men with advanced prostate cancer by using better imaging techniques to target the cancer more precisely and reduce side effects.

  Recruiting British Columbia Cancer Agency · Vancouver, British Columbia · NCT03836196

• High dose rate brachytherapy for recurrent prostate cancer

  This study is testing if a special type of radiation therapy can help men with recurrent prostate cancer feel better and control their cancer after previous treatment.

  Recruiting British Columbia Cancer Agency · Kelowna, British Columbia · NCT03246802

• Understanding genetic changes in metastatic pancreatic cancer

  This study is trying to understand the genetic changes in pancreatic cancer by looking at tumor and blood samples from patients starting chemotherapy to see if these changes can help tailor better treatments for them.

  Recruiting British Columbia Cancer Agency · Calgary, Alberta and 3 other locations · NCT02869802

• Personalized cancer treatment based on genomic analysis

  This study is testing whether personalized cancer treatments based on each patient's unique genetic makeup can improve outcomes for people with advanced cancers.

  Recruiting British Columbia Cancer Agency · Vancouver, British Columbia · NCT02155621

Quick answers

How many clinical trials run by British Columbia Cancer Agency are recruiting right now?

24, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Canada (24 trials), Ireland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →